Cargando…
Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy
There are two figures and one table in this review, the review consists of 5823 words, without the description of figures and table, but including references. Tumor cells escape anti-tumor immune responses in various ways, including functionally shaping the microenvironment through the secretion of...
Autores principales: | Liu, Zhaoyun, Liu, Xiaohan, Shen, Hongli, Xu, Xintong, Zhao, Xianghong, Fu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493240/ https://www.ncbi.nlm.nih.gov/pubmed/36159861 http://dx.doi.org/10.3389/fimmu.2022.978377 |
Ejemplares similares
-
Therapeutic strategies to enhance immune response induced by multiple myeloma cells
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Immune checkpoint inhibitors for multiple myeloma immunotherapy
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
por: Kurago, Zoya, et al.
Publicado: (2023) -
Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy
por: Steingold, Joseph M., et al.
Publicado: (2020) -
Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
por: Jin, Ketao, et al.
Publicado: (2021)